Skip to main content
Daito Pharmaceutical Co., Ltd. logo

Daito Pharmaceutical Co., Ltd. — Investor Relations & Filings

Ticker · 4577 ISIN · JP3486150000 T Manufacturing
Open in API
Filings indexed 76 across all filing types
Latest filing 2019-08-30 Annual Report
Country JP Japan
Listing T 4577

About Daito Pharmaceutical Co., Ltd.

https://www.eng.daitonet.co.jp/

Daito Pharmaceutical Co., Ltd. is a manufacturer specializing in the integrated production of pharmaceuticals, from active pharmaceutical ingredients (APIs) to finished formulation products. The company's core activities include the development and supply of APIs, primarily for generic drugs, and the manufacturing of generic and over-the-counter (OTC) medications. Additionally, Daito provides contract manufacturing services for various pharmaceutical products. The company emphasizes a comprehensive quality assurance system to ensure the stable supply of high-quality products to its clients.

Recent filings

Filing Released Lang Actions
有価証券報告書－第77期(平成30年6月1日－令和1年5月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains a formal cover page, fiscal year details (第77期), and extensive XBRL-like metadata tags indicating comprehensive financial reporting for the period 2018-06-01 to 2019-05-31. It is clearly the full annual report rather than an announcement or summary. FY 2019
2019-08-30 Japanese
四半期報告書－第77期第3四半期(2018/12/01－2019/02/28)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Daito Pharmaceutical Co., Ltd. for the third quarter of the 77th fiscal year. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement, as well as notes to the financial statements and management analysis. This meets the criteria for an Interim/Quarterly Report (IR) as it provides substantive financial data and analysis for a period shorter than a full fiscal year. 9M 2019
2019-04-12 Japanese
四半期報告書－第77期第2四半期(2018/09/01－2018/11/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Daito Pharmaceutical Co., Ltd., covering the second quarter of the 77th fiscal year (September 1, 2018, to November 30, 2018). It contains detailed financial statements, including the balance sheet, income statement, and cash flow statement, as required by the Financial Instruments and Exchange Act of Japan. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). H1 2019
2019-01-11 Japanese
四半期報告書－第77期第1四半期(2018/06/01－2018/08/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '第１四半期報告書' (First Quarter Report) for Daito Pharmaceutical Co., Ltd., covering the period from June 1, 2018, to August 31, 2018. It contains detailed financial statements, including the balance sheet, income statement, and notes to the financial statements, as required by the Financial Instruments and Exchange Act of Japan. Since it is a comprehensive financial report for a period shorter than a full fiscal year and contains actual financial data, it is classified as an Interim/Quarterly Report (IR). Q1 2019
2018-10-12 Japanese
有価証券報告書－第76期(平成29年6月1日－平成30年5月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains comprehensive financial data, including consolidated and non-consolidated financial indicators, balance sheets, and income statements for the fiscal year ending May 31, 2018. It is a formal regulatory filing submitted to the Hokuriku Finance Bureau under the Financial Instruments and Exchange Act. FY 2018
2018-08-30 Japanese
四半期報告書－第76期第3四半期(2017/12/01－2018/02/28)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Hokuriku Local Finance Bureau under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, including the balance sheet, income statement, and comprehensive income statement for the third quarter of the fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). 9M 2018
2018-04-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.